Lifestyle Modifications May Slow MASLD Through Key Molecular Mechanism: Study

Exercise and meal timing may protect your liver by switching off a harmful molecular pathway, new research suggests.

Lifestyle changes such as regular exercise and healthy eating are the main treatments for metabolic dysfunction-associated steatotic liver disease (MASLD), a condition previously known as fatty liver disease. Now, researchers have discovered how these habits may protect the liver at a molecular level.

The study, published in eGastroenterology, found that exercise and time-restricted eating improve liver health by lowering the levels of a small molecule called miR-802.

MASLD is more than just fat building up in the liver. It can also cause inflammation, liver cell damage, and long-term metabolic problems.

Researchers found that miR-802 levels were much higher in mice and people with MASLD. Higher levels of this molecule caused liver cells to store more fat, cholesterol, and triglycerides, making the disease worse.

However, when researchers blocked miR-802, the liver stored less fat and showed fewer signs of damage.

The team then studied mice fed a high-fat diet. Mice that exercised regularly or followed an 8-hour time-restricted eating schedule had lower levels of miR-802, less fat in their livers, and better overall liver health.

When researchers artificially increased miR-802 again, many of these benefits disappeared, suggesting that lowering this molecule is one way exercise and meal timing protect the liver.

The researchers also identified a chain of events behind this effect. A protein called PPARγ increases miR-802 levels. In turn, miR-802 blocks another protein called Psmd2, which normally helps maintain healthy fat metabolism. This chain of events eventually leads to excess fat building up in the liver.

The researchers say this pathway could become a future treatment target for MASLD. They also believe that measuring miR-802 in the blood could one day help doctors monitor how well lifestyle changes are working. However, larger human studies are still needed to confirm these findings.

REFERENCE: Liu, Y., et al. (2026) Exercise and dietary interventions ameliorate MASLD via the hepatic PPARγ-miR-802-Psmd2 axis. eGastroenterology. DOI: 10.1136/egastro-2025-100334. https://egastroenterology.bmj.com/content/4/1/e100334